中华疝和腹壁外科杂志(电子版)
中華疝和腹壁外科雜誌(電子版)
중화산화복벽외과잡지(전자판)
CHINESE JOURNAL OF HERNIA AND ABDOMINAL WALL SURGERY(ELECTRONIC VERSION)
2015年
4期
302-305
,共4页
曹廷宝%韩晓鹏%李三党%李东伟%魏登文%景化忠%刘宏斌
曹廷寶%韓曉鵬%李三黨%李東偉%魏登文%景化忠%劉宏斌
조정보%한효붕%리삼당%리동위%위등문%경화충%류굉빈
肥胖%疝修补术%腹腔镜
肥胖%疝脩補術%腹腔鏡
비반%산수보술%복강경
Hernia%Obesity%Herniorrhaphy%Laparoscopes
目的:探讨肥胖患者巨大切口疝的微创手术治疗效果及并发症。方法回顾性分析2009年7月至2013年12月,兰州军区兰州总医院21例肥胖巨大切口疝患者行腹腔镜切口疝修补术的临床资料。结果本组21例患者,中转开腹1例,顺利完成手术20例。手术时间75~230 min,平均(124±39)min,术后随访4~49个月,复发1例(5%);腹壁疼痛1例(5%);血清肿1例(5%);无手术部位感染、腹腔间室综合征等严重并发症。结论腹腔镜巨大切口疝修补术应用于肥胖患者,具有微创、恢复快、并发症小及复发率低等优势,值得临床推广应用。
目的:探討肥胖患者巨大切口疝的微創手術治療效果及併髮癥。方法迴顧性分析2009年7月至2013年12月,蘭州軍區蘭州總醫院21例肥胖巨大切口疝患者行腹腔鏡切口疝脩補術的臨床資料。結果本組21例患者,中轉開腹1例,順利完成手術20例。手術時間75~230 min,平均(124±39)min,術後隨訪4~49箇月,複髮1例(5%);腹壁疼痛1例(5%);血清腫1例(5%);無手術部位感染、腹腔間室綜閤徵等嚴重併髮癥。結論腹腔鏡巨大切口疝脩補術應用于肥胖患者,具有微創、恢複快、併髮癥小及複髮率低等優勢,值得臨床推廣應用。
목적:탐토비반환자거대절구산적미창수술치료효과급병발증。방법회고성분석2009년7월지2013년12월,란주군구란주총의원21례비반거대절구산환자행복강경절구산수보술적림상자료。결과본조21례환자,중전개복1례,순리완성수술20례。수술시간75~230 min,평균(124±39)min,술후수방4~49개월,복발1례(5%);복벽동통1례(5%);혈청종1례(5%);무수술부위감염、복강간실종합정등엄중병발증。결론복강경거대절구산수보술응용우비반환자,구유미창、회복쾌、병발증소급복발솔저등우세,치득림상추엄응용。
Objective To explore the clinical effect and complications of the minimally invasive surgical therapy for huge incisional hernia in obese patients .Methods A retrospective analysis was conducted on 21 obese patients with giant incisional hernia , who underwent laparoscopic incisional hernia repair ( LIHR) from July 2009 to December 2013 in Lanzhou Army General Hospital .Results Of these patients, one converted to laparotomy , and 20 cases were successfully completed with LIHR .The operative time were 75 to 230 minutes, average of (124 ±39) minutes.All patients were followed up for 4 to 49 months;one recurrence (5%), one abdominal pain (5%) and one seroma (5%) occurred;there were no serious complications ( such as surgical site infections , abdominal compartment syndrome , etc.) . Conclusion LIHR for huge incisional hernia in obese patients has been showed to be minimally invasive , quick recovery , low complications and recurrence rate , and it is worthy of clinical promotion .